Cargando…

Trend analysis of antibiotic resistance and minimum inhibitory concentration distribution from 1997 to 2007 among Pseudomonas aeruginosa, Escherichia coli and Klebsiella pneumoniae in European ICUs

Detalles Bibliográficos
Autores principales:	Hanberger, H, Gill, H, Fransson, G, Nilsson, L, Turner, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084188/ http://dx.doi.org/10.1186/cc7466

Ejemplares similares

Sub-minimum inhibitory concentrations of biocides induced biofilm formation in Pseudomonas aeruginosa
por: Hemati, S., et al.
Publicado: (2020)

Effect of Sub-Minimum Inhibitory Concentrations of Tyrosol and EDTA on Quorum Sensing and Virulence of Pseudomonas aeruginosa
por: Abdel-Rhman, Shaymaa H, et al.
Publicado: (2020)

Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies
por: Grillon, Antoine, et al.
Publicado: (2016)

Effects of Sub-Minimum Inhibitory Concentrations of Gentamicin on Alginate Produced by Clinical Isolates of Pseudomonas aeruginosa
por: Saidi, Navid, et al.
Publicado: (2023)

Prevalence of infections among patients admitted to ICUs in Nordic countries and the Netherlands in comparison with Mediterranean countries: a report from the EPIC II study
por: Hanberger, H, et al.
Publicado: (2010)

1583. In Vitro Activity of Imipenem/Relebactam against Klebsiella pneumoniae and Pseudomonas aeruginosa from Patients in ICUs in the Asia/Pacific region – SMART 2015-2018
por: Lob, Sibylle, et al.
Publicado: (2020)

Tracking Pseudomonas aeruginosa transmissions due to environmental contamination after discharge in ICUs using mathematical models
por: Pham, Thi Mui, et al.
Publicado: (2019)

2805. Extended-Infusion versus Intermittent-Infusion Piperacillin/tazobactam for High Minimum Inhibitory Concentration Pseudomonas aeruginosa Infections
por: Shifko, Carlee R, et al.
Publicado: (2023)

Developing an in silico minimum inhibitory concentration panel test for Klebsiella pneumoniae
por: Nguyen, Marcus, et al.
Publicado: (2018)

Antimicrobial Properties of the Polyaniline Composites against Pseudomonas aeruginosa and Klebsiella pneumoniae
por: Maruthapandi, Moorthy, et al.
Publicado: (2020)

In vitro Reducing Effect of Cloxacillin on Minimum Inhibitory Concentrations to Imipenem, Meropenem, Ceftazidime, and Cefepime in Carbapenem-resistant Pseudomonas aeruginosa Isolates
por: Pahlavanzadeh, Farahnaz, et al.
Publicado: (2020)

Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis
por: Lasko, Maxwell J., et al.
Publicado: (2021)

Different effects of sub-minimum inhibitory concentrations of gentamicin on the expression of genes involved in alginate production and biofilm formation of Pseudomonas aeruginosa
por: Davarzani, Fateme, et al.
Publicado: (2021)

1256. Clinical Response by Minimum Inhibitory Concentrations in Carbapenem-Resistant Pseudomonas aeruginosa Infections under Cefiderocol Compassionate Use Program
por: Satlin, Michael J, et al.
Publicado: (2021)

Predictive factors of in-hospital mortality in patients with laboratory-confirmed Escherichia coli, Klebsiella species or Pseudomonas aeruginosa bloodstream infections
por: Mitchell, Eleanor, et al.
Publicado: (2021)

Minimum inhibitory concentrations of erythromycin and rifampin for Rhodococcus equi during the years 2007–2014
por: Fenton, Caitriona S., et al.
Publicado: (2015)

Ecthyma Gangrenosum: Escherichia coli or Pseudomonas aeruginosa?
por: Abbas, Mohamed, et al.
Publicado: (2017)

Sub-Inhibitory Antibiotic Exposure and Virulence in Pseudomonas aeruginosa
por: Nolan, Charlotte, et al.
Publicado: (2021)

Appropriateness of Empirical Fluoroquinolones Therapy in Patients Infected with Escherichia coli, Klebsiella pneumoniae, or Pseudomonas aeruginosa: The Importance of the CLSI Breakpoints Revision
por: Wang, Ying, et al.
Publicado: (2021)

Epidemiology and mortality outcome of carbapenem- and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections
por: Balkhair, A., et al.
Publicado: (2023)

Evaluation of the BD Phoenix Carbapenemase-Producing Organism Panels for the Detection of Carbapenemase Producers in Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa
por: Correa-León, Yoselin Paola, et al.
Publicado: (2023)

Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates
por: Lu, Peggy, et al.
Publicado: (2023)

In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
por: Lee, Bosul, et al.
Publicado: (2021)

13. Evaluation of Etest for Antibiotic Susceptibility and Minimum Inhibitory Concentration (MIC) Agreement Against pseudomonas Aeruginosa (psa) from Patients with Cystic Fibrosis (CF)
por: Lasko, Maxwell J, et al.
Publicado: (2020)

eMIC-AntiKP: Estimating minimum inhibitory concentrations of antibiotics towards Klebsiella pneumoniae using deep learning
por: Nguyen, Quang H., et al.
Publicado: (2022)

Escherichia coli infection in Polish neonatology ICUs in 2009 to 2012
por: Wójkowska-Mach, J, et al.
Publicado: (2014)

Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infection: A Serious Threat in ICUs
por: Ulu, Aslıhan Candevir, et al.
Publicado: (2015)

Emerging and re-emerging viruses in Malaysia, 1997–2007
por: Tee, Kok Keng, et al.
Publicado: (2009)

In vitro activity of imipenem ± aminoglycosides against Pseudomonas aeruginosa and Acinetobacter calcoaceticus / baumanii isolated from patients in ICUs in German hospitals (1999–2002)
por: Mueller, EE, et al.
Publicado: (2003)

Understanding and predicting ciprofloxacin minimum inhibitory concentration in Escherichia coli with machine learning
por: Pataki, Bálint Ármin, et al.
Publicado: (2020)

Metallo-β-lactamase and AmpC genes in Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolates from abattoir and poultry origin in Nigeria
por: Ejikeugwu, Chika, et al.
Publicado: (2021)

Biomolecular Mechanisms of Pseudomonas aeruginosa and Escherichia coli Biofilm Formation
por: Laverty, Garry, et al.
Publicado: (2014)

The behaviour of Escherichia coli and Pseudomonas aeruginosa in bottled mineral water
por: Schalli, Michael, et al.
Publicado: (2023)

Emergence of Ceftazidime- and Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Pseudomonas aeruginosa in China
por: Zhu, Yiwei, et al.
Publicado: (2021)

Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection
por: Le Guern, Rémi, et al.
Publicado: (2023)

Admission screening and cohort care decrease carbapenem resistant enterobacteriaceae in Vietnamese pediatric ICU’s
por: Garpvall, K., et al.
Publicado: (2021)

Polyclonal Endemicity of Carbapenemase-Producing Klebsiella pneumoniae in ICUs of a Greek Tertiary Care Hospital
por: Protonotariou, Efthymia, et al.
Publicado: (2022)

Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009)
por: Kateete, David P., et al.
Publicado: (2016)

In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019
por: Karlowsky, James A., et al.
Publicado: (2022)

Specificity in the Susceptibilities of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus Clinical Isolates to Six Metal Antimicrobials
por: Gugala, Natalie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_en3qchf5dkjmtl0ufhj7d6a8d6